Search

everythinglearnresearchcommunity

for

Search:↓

A substance from Caulerpa racemosa seaweed may protect against skin damage caused by air pollution by reducing oxidative stress and cell death.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Low-dose rapamycin microdepots can help regrow hair by activating certain cell processes.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Recognizing skin symptoms helps diagnose and treat frontal fibrosing alopecia.

The fibroin-based formulation strengthens and repairs chemically damaged hair.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Tofacitinib may help treat hair loss in children with alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Zebrafish skin regeneration relies on cell behaviors and reactive oxygen species, with antioxidants reducing and hydrogen peroxide increasing regeneration.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Rabies virus was found in specific skin cells of rabid dogs' muzzles, suggesting these cells could help diagnose rabies.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

Mimicking fetal wound environments may enable scarless healing in adults.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

The new patch made of cell matrix and a polymer improves wound healing and supports blood vessel growth.

The new gel effectively treats MRSA-infected wounds for longer.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.